A

Anthem Inc
LSE:0HG8

Watchlist Manager
Anthem Inc
LSE:0HG8
Watchlist
Price: 415.21 USD 0.01% Market Closed
Market Cap: 107.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Net Income
Loading...

Wall Street
Price Targets

0HG8 Price Targets Summary
Anthem Inc

Wall Street analysts forecast 0HG8 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0HG8 is 500.39 USD with a low forecast of 425.69 USD and a high forecast of 604.88 USD.

0HG8 Lowest Forecast
Wall Street Target
425.69 USD
3% Upside
0HG8 Average Forecast
Wall Street Target
500.39 USD
21% Upside
0HG8 Highest Forecast
Wall Street Target
604.88 USD
46% Upside
Lowest
Price Target
425.69 USD
3% Upside
Average
Price Target
500.39 USD
21% Upside
Highest
Price Target
604.88 USD
46% Upside
Anthem Inc Competitors:
Price Targets
PGNY
Progyny Inc
19% Upside
ODPV3
Odontoprev SA
17% Upside
HQY
Healthequity Inc
26% Upside
CLOV
Clover Health Investments Corp
26% Upside
PGNY
Progyny Inc
19% Upside
ODPV3
Odontoprev SA
17% Upside
HQY
Healthequity Inc
26% Upside
CLOV
Clover Health Investments Corp
26% Upside
MOH
Molina Healthcare Inc
16% Upside

Revenue
Forecast

Revenue Estimate
Anthem Inc

For the last 8 years the compound annual growth rate for Anthem Inc's revenue is 10%. The projected CAGR for the next 3 years is 9%.

10%
Past Growth
9%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Anthem Inc

For the last 8 years the compound annual growth rate for Anthem Inc's net income is 12%. The projected CAGR for the next 3 years is 20%.

12%
Past Growth
20%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

See Also

Summary
0HG8 intrinsic value, competitors valuation, and company profile.
DCF Valuation
0HG8 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0HG8 stock valuation using valuation multiples.
Wall Street Estimates
0HG8 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0HG8 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0HG8's stock price target?
Price Target
500.39 USD

According to Wall Street analysts, the average 1-year price target for 0HG8 is 500.39 USD with a low forecast of 425.69 USD and a high forecast of 604.88 USD.

What is Anthem Inc's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Anthem Inc's revenue is 10%. The projected CAGR for the next 3 years is 9%.

What is Anthem Inc's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Anthem Inc's net income is 12%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.